Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Lifestyle Natural Medicines

Gulf Resources (NASDAQ:GURE) Shares Pass Above 200-Day Moving Average of $1.40

Shares of Gulf Resources, Inc. (NASDAQ:GURE – Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $1.40 and traded as high as $1.65. Gulf Resources shares last traded at $1.2

By: ETF Daily News

Jul 06 2024
1
287 Views

Shares of Gulf Resources, Inc. (NASDAQ:GURE – Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $1.40 and traded as high … [+1119 chars]

Related

OMass Therapeutics Expands Development Team with Key Appointments in US and UK and Announces the Nomination of Clinical Candidate Against MC2

Wegovy weight loss: The science and the hype of supplements

Eli Lilly plans $4.5 billion facility in LEAP District, bringing investment to $13 billion

5 Myths of Antidepressants and Why I Needed to Bust Them

Renaissance Technologies LLC Has $4.11 Million Holdings in Nektar Therapeutics (NASDAQ:NKTR)

Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024

Queen Elizabeth Was Secretly Dying of Cancer, Ex-PM says

Gulf Resources (NASDAQ:GURE) Issues Quarterly Earnings Results

Korro Announces Oral and Poster Presentations at the 20th Annual Meeting of the Oligonucleotide Therapeutics Society

90+ New Target Circle Offers: All 20% to 50% off Deals!

Groundbreaking Study Demonstrates Clinical Benefits Of Planting Trees: The Green Heart Louisville Project Reveals How

Funding The Future: Sustainable Financing Models To Help The Fight Against Antimicrobial Resistance

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

Next

OMass Therapeutics Expands Development Team with Key Appointments in US and UK and Announces the Nomination of Clinical Candidate Against MC2